Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Innovex Announces Fireside Chat Featuring CEO Adam Anderson and Investor Vitaliy Katsenelson
-
Why Crypto Startups Are Struggling to Attract VC Funding
-
Banzai Reports Fourth Quarter and Full Year 2025 Financial Results
-
Trust Stamp provides a comprehensive business briefing for Q1 of 2026 reporting strong progress across multiple business geographies and verticals
-
Trust Stamp filed its 10-K for the year ending December 31, 2025 reflecting strong growth in customer enrollments and user completions with a 33.6% year-on-year decrease in Comprehensive Operating Los
-
CMB.TECH announces final year results
-
BioAtla Announces Share Consolidation
-
Rich Butkus Shares CPA's Multi-State Growth at ReNew Summit
-
RH Reports Fourth Quarter and Fiscal Year 2025 Results
-
19.40m @ 17.29 g/t Au in Hole BO-26-63 at Bousquet
-
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
-
Nano Dimension Announces Financial Results for the Fourth Quarter and Full Year 2025
-
Workhorse Group Reports Fourth Quarter and Full Year 2025 Results
-
Dave & Buster’s Reports Fourth Quarter and Fiscal Year End 2025 Financial Results
-
Global Crossing Airlines Reports Fleet Expansion Milestones and Participation in Upcoming Investor Conferences
-
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
-
Sportsman’s Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results
-
TruBridge Announces Fourth Quarter and Full Year 2025 Results
-
Barfresh Announces Fourth Quarter and Full Year 2025 Results
-
Birchtech Reports Fourth Quarter 2025 Financial Results
-
Rigetti Announces Novera QPU Sale to the University of Saskatchewan
-
SEALSQ Announces FY 2025 Audited Financial Results, Reaffirms Q1 2026 Expectations & FY 2026 Guidance, Updates on Partnerships and QS7001 Certification & Go-to-Market Execution
-
TOMI Environmental Solutions, Inc. Reports Full Year 2025 Financial Results and Outlines Growth Initiatives
-
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
-
JFrog Brings Enterprise-Grade Software Supply Chain Security to Over 1M AI Developers with New Cursor AI Coding Agent
-
AM Best Downgrades Credit Ratings of Cities and Villages Mutual Insurance Company
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Andrea Brimmer to Transition from eHealth Board of Directors
-
Accelerant Completes CFO Transition
-
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
-
Curaleaf to Report First Quarter 2026 Financial and Operational Results
-
Rekor Systems Reports Full Year 2025 Results
-
Albertsons® Companies Announces Fourth Quarter and Fiscal 2025 Earnings Release and Conference Call Date
-
VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update
-
Advisory for Tuesday, April 28: Edison International to Hold Conference Call on First Quarter Financial Results
-
LibertyStream Shareholders Approve Texas Re-Domiciliation as Company Advances U.S. Listing Pathway and Texas Build-Out
-
BRC Group Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
-
Ulta Beauty to Participate in Upcoming Investor Conference
-
Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
-
AVAX One Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
-
MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter
-
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
-
PEOPLES BANCORP INC. TO ANNOUNCE 1ST QUARTER 2026 EARNINGS AND CONDUCT CONFERENCE CALL ON APRIL 21, 2026
-
ORIC® Pharmaceuticals Reports Selection of Rinzimetostat RP3D in Combination with Darolutamide for Himalayas-1 Phase 3 Global Study with Dose Optimization Data Supporting Its Potential Best-in-Diseas
-
authID Reports Financial and Operating Results for the Fourth Quarter 2025
-
SEALSQ Announces FY 2025 Audited Financial Results, Reaffirms Q1 2026 Expectations & FY 2026 Guidance, Updates on Partnerships and QS7001 Certification & Go-to-Market Execution
-
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
-
Datacentrex Announces Closing of $20.17 Million Public Offering
-
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
